Omeros Corporation

356 articles with Omeros Corporation

• Omeros Corporation Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program

  1/28/2009

• Omeros Corporation Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target

  1/7/2009

• Omeros Corporation Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery

  12/9/2008

• Omeros Corporation and BlueCrest Announce $20 Million Debt Facility

  9/24/2008

• Omeros Corporation and The Parkinson's Institute Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders

  9/17/2008

• Omeros Corporation Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302

  9/9/2008

• Omeros Corporation Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery

  8/26/2008

• Affitech AS and Omeros Corporation Enter Into Antibody Discovery and Development Agreement

  8/19/2008

• Omeros Corporation Appoints David A. Mann to its Board of Directors

  8/13/2008

• Omeros Corporation Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study

  5/21/2008

• Omeros Corporation Files for $115 Million IPO

  1/10/2008

• Omeros Corporation Raises More Than $63 Million In Financing

  2/13/2007

• Omeros Corporation Receives Up To $9 Million Toward Development Of Schizophrenia Treatment

  1/10/2007

• Paul Strauss, M.D. Joins Omeros Corporation As VP, Clinical Development

  10/17/2006

• Omeros Corporation Acquires Nura, Inc.; Acquisition Adds World-Renowned Scientists And Expands Pipeline

  9/7/2006

• Omeros Corporation Names Greg Perkins, Ph.D., As Vice President, Regulatory Affairs

  8/22/2006